so you think they'll go through all the work to implement ph3 not not see it through to the finish? Did you not hear JPs talk about building value. He stated progressing as far as he can to build value. Sheesh, he didn't even rule out commercialising the drug.
The two primary things I take away from the webinar:
1. JP attributes reduction in share price to reduction in Daybue
sentiment.
2. JP considers independently advancing the pipeline with existing and incoming capital the best way to increase value.
so you think they'll go through all the work to implement ph3...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |